WallStSmart
OGN

Organon & Co

NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$13.34
+0.15% today

Updated 2026-04-29

Market cap
$3.50B
P/E ratio
18.53
P/S ratio
0.56x
EPS (TTM)
$0.72
Dividend yield
2.55%
52W range
$6 – $13
Volume
9.4M

Organon & Co (OGN) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$10.50B$9.78B$7.78B$6.53B$6.30B$6.17B$6.26B$6.40B$6.22B
Revenue growth (YoY)-6.9%-20.5%-16.0%-3.5%-2.1%+1.4%+2.2%-2.9%
Cost of revenue$4.59B$4.69B$2.27B$2.12B$2.38B$2.29B$2.52B$2.69B$2.85B
Gross profit$5.91B$5.08B$5.50B$4.41B$3.92B$3.88B$3.75B$3.71B$3.36B
Gross margin56.3%52.0%70.8%67.6%62.2%62.8%59.8%58.0%54.1%
R&D$355.00M$365.00M$220.00M$210.00M$443.00M$471.00M$528.00M$469.00M$366.00M
SG&A$1.93B$1.69B$1.18B$1.16B$1.43B$1.45B$1.68B$1.55B$1.72B
Operating income$3.27B$2.71B$3.85B$2.85B$1.92B$1.71B$1.33B$1.49B$1.28B
Operating margin31.2%27.7%49.5%43.6%30.4%27.6%21.2%23.2%20.7%
EBITDA$5.08B$4.38B$3.92B$2.99B$1.98B$1.76B$1.44B$1.60B$1.28B
EBITDA margin48.4%44.8%50.3%45.8%31.4%28.4%22.9%25.1%20.6%
EBIT$3.11B$2.71B$3.56B$2.85B$1.79B$1.54B$1.20B$1.33B$929.00M
Interest expense$21.00M$45.00M$6.00M$6.00M$258.00M$422.00M$527.00M$520.00M$504.00M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$1.80B$2.15B$3.22B$2.16B$1.35B$917.00M$1.02B$864.00M$187.00M
Net income growth (YoY)+19.5%+49.5%-32.9%-37.5%-32.1%+11.6%-15.5%-78.4%
Profit margin17.2%22.0%41.4%33.1%21.4%14.9%16.3%13.5%3.0%